Benzinga's Top Pre-Market NASDAQ Gainers (SPPI, IBKR, DRYS, RYAAY)

Spectrum Pharmaceuticals Inc SPPI rose 6.28% to $5.75 in the pre-market session. SPPI's cancer drug Zevalin depicted positive outcome in a recent study. Interactive Brokers Group Inc IBKR added 3.17% to $17.88 in pre-market trading. IBKR reported a 14% y/y rise in its November trading volume. DryShips Inc DRYS moved up 2.58% to $6.37 in pre-market trading. DRYS' subsidiary announced its plans to raise $500 million in a private offering. Ryanair Holdings plc RYAAY gained 2.06% to $31.18 in the pre-market session. RYAAY's PEG ratio is 0.92. Read more from Benzinga's Markets.